Professor Gokhan Hotamisligil Receives 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence
- Written by Admin TOA
- Published in Academicians
Turkish American Professor Gokhan S. Hotamisligil received the 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence for his outstanding research efforts that have led to groundbreaking new knowledge about the relationship between obesity and diabetes and potential paths for treatment.
Professor Hotamisligil is a Turkish American physician scientist; James Stevens Simmons Professor of Genetics and Metabolism; chair of the Department of Genetics and Complex Diseases at Harvard T.H. Chan School of Public Health (HSPH); director of the Sabri Ulker Center for Metabolic Research and associate member of Harvard-MIT Broad Institute, Harvard Stem Cell Institute and the Joslin Diabetes Center.
The Prize is awarded in collaboration between the European Association for the Study of Diabetes (EASD) and the Novo Nordisk Foundation to recognize outstanding research or technology contributions to the understanding of diabetes, its disease mechanisms or its complications. The Prize is accompanied by DKK 6 million (approximately one million U.S. dollars) for personal and research purposes.
Last modified onWednesday, 19 September 2018 22:41
Tagged under
Related items
Latest from Admin TOA
- Hiram & Solomon Cigars Introduces the Patriot Cigar Honoring M.W. George F. Hamilton, 91st Grand Master of Masons in Massachusetts
- PCA Officially Announces 2025 Trade Show Dates
- Galaxy Group Gets DO&CO Detroit Project
- Necla Ozkan Joins Coldwell Banker Realty’s 2024 Sterling Society for Outstanding Sales Performance
- "Discovering Hidden Gems: Inspiring Stories from New York Life & Beyond"
